GANNON STEVEN sold 86.7% of their position (13K shares) of XENON PHARMACEUTICALS INC. on the open market
Open‑market sale worth $601.6K — a major position exit. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 4 sales
Filed: 3/8/2024ACC: 0000950170-24-028788
-13K
Net shares
Net seller
$601.6K
Total sold
4
Open market trades
0B · 4S
4
Total transactions
13K disposed
Non-Derivative Transactions4
Common Shares
Direct
Shares
−1K
Price / share
$46.45
Trade value
$46.45K
% of position
6.7%
3/7/2024
15K→14K
Common Shares
Direct
Shares
−5K
Price / share
$46.25
Trade value
$231.25K
% of position
35.7%
3/7/2024
14K→9K
Common Shares
Direct
Shares
−5K
Price / share
$46.30
Trade value
$231.51K
% of position
55.6%
3/7/2024
9K→4K
Common Shares
Direct
Shares
−2K
Price / share
$46.20
Trade value
$92.40K
% of position
50.0%
3/7/2024
4K→2K
Total
Net shares
−13K
Net value
-$601.61K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Shares Direct | 3/7/2024 | S · Sale | −1K | $46.45 | $46.45K | 6.7% | 15K | 14K |
| Common Shares Direct | 3/7/2024 | S · Sale | −5K | $46.25 | $231.25K | 35.7% | 14K | 9K |
| Common Shares Direct | 3/7/2024 | S · Sale | −5K | $46.30 | $231.51K | 55.6% | 9K | 4K |
| Common Shares Direct | 3/7/2024 | S · Sale | −2K | $46.20 | $92.40K | 50.0% | 4K | 2K |
| Total | −13K | -$601.61K | ||||||
Derivative Transactions0
No derivative transactions reported